Calithera Biosciences, Inc. (CALA) Reaches $6.95 After 8.00% Down Move; South State (SSB) Had 4 Bullish Analysts

February 15, 2018 - By Richard Conner

Among 8 analysts covering South State Corp (NASDAQ:SSB), 4 have Buy rating, 0 Sell and 4 Hold. Therefore 50% are positive. South State Corp had 26 analyst reports since July 28, 2015 according to SRatingsIntel. On Wednesday, November 30 the stock rating was initiated by Brean Capital with “Hold”. The firm earned “Hold” rating on Thursday, October 26 by Piper Jaffray. Wood upgraded the stock to “Outperform” rating in Tuesday, July 25 report. The firm has “Outperform” rating by FIG Partners given on Monday, January 25. Brean Capital maintained the shares of SSB in report on Monday, January 29 with “Hold” rating. SunTrust maintained it with “Buy” rating and $102 target in Thursday, October 26 report. The rating was reinitiated by PiperJaffray with “Neutral” on Thursday, October 5. The stock has “Hold” rating by Brean Capital on Friday, December 1. The stock has “Buy” rating by SunTrust on Tuesday, November 28. The company was maintained on Monday, October 23 by Brean Capital. See South State Corporation (NASDAQ:SSB) latest ratings:

05/02/2018 Broker: Brean Capital Rating: Hold Maintain
29/01/2018 Broker: Brean Capital Rating: Hold Maintain
24/01/2018 Broker: SunTrust Rating: Buy New Target: $108.0 Maintain
23/01/2018 Broker: Brean Capital Rating: Hold Maintain
08/01/2018 Broker: SunTrust Rating: Buy New Target: $112.0 Maintain
02/01/2018 Broker: Brean Capital Rating: Hold Maintain
21/12/2017 Broker: Keefe Bruyette & Woods Rating: Buy New Target: $100.0 Maintain
01/12/2017 Broker: Brean Capital Rating: Hold Maintain
28/11/2017 Broker: SunTrust Rating: Buy New Target: $107.0 Maintain
30/10/2017 Broker: Brean Capital Rating: Hold Maintain

The stock of Calithera Biosciences, Inc. (NASDAQ:CALA) is a huge mover today! The stock decreased 2.11% or $0.15 during the last trading session, reaching $6.95. About 417,005 shares traded. Calithera Biosciences, Inc. (NASDAQ:CALA) has risen 278.82% since February 15, 2017 and is uptrending. It has outperformed by 262.12% the S&P500.The move comes after 5 months negative chart setup for the $246.56 million company. It was reported on Feb, 15 by Barchart.com. We have $6.39 PT which if reached, will make NASDAQ:CALA worth $19.73 million less.

South State Corporation operates as the bank holding firm for South State Bank that provides a range of retail and commercial banking services, mortgage lending services, trust and investment services, and consumer finance loans. The company has market cap of $3.24 billion. It accepts demand deposits, savings deposits, interest-bearing demand deposits, certificates of deposit, and other time deposits; and offers lending and credit card, ATM processing, and wealth management and trust services. It has a 30.31 P/E ratio. The firm also provides investment advisory and broker dealer services.

The stock decreased 0.23% or $0.2 during the last trading session, reaching $88.8. About 60,994 shares traded. South State Corporation (NASDAQ:SSB) has risen 19.60% since February 15, 2017 and is uptrending. It has outperformed by 2.90% the S&P500.

Investors sentiment decreased to 1.22 in Q3 2017. Its down 2.03, from 3.25 in 2017Q2. It worsened, as 16 investors sold Calithera Biosciences, Inc. shares while 21 reduced holdings. 14 funds opened positions while 31 raised stakes. 25.24 million shares or 49.47% less from 49.95 million shares in 2017Q2 were reported. Bnp Paribas Arbitrage stated it has 0% in Calithera Biosciences, Inc. (NASDAQ:CALA). 167,467 are owned by Deutsche Natl Bank Ag. Citigroup Incorporated invested in 0% or 57,938 shares. Gru One Trading L P accumulated 26,036 shares. Vanguard Grp invested in 1.10M shares. Jacobs Levy Equity Mgmt has invested 0.01% in Calithera Biosciences, Inc. (NASDAQ:CALA). Credit Suisse Ag owns 31,371 shares for 0% of their portfolio. Clarivest Asset Mngmt Ltd Liability Corporation accumulated 49,474 shares or 0.02% of the stock. Dupont Cap Mngmt Corporation reported 16,394 shares. Tower Rech Cap Ltd Company (Trc) holds 0% of its portfolio in Calithera Biosciences, Inc. (NASDAQ:CALA) for 174 shares. Wellington Mngmt Limited Liability Partnership reported 0.02% stake. Utd Automobile Association owns 48,750 shares or 0% of their US portfolio. Alliancebernstein L P owns 22,600 shares or 0% of their US portfolio. Royal National Bank & Trust Of Canada reported 3,159 shares or 0% of all its holdings. Moreover, Ascend Cap Lc has 0.39% invested in Calithera Biosciences, Inc. (NASDAQ:CALA) for 658,195 shares.

Among 5 analysts covering Calithera Biosciences (NASDAQ:CALA), 4 have Buy rating, 0 Sell and 1 Hold. Therefore 80% are positive. Calithera Biosciences has $1900 highest and $9 lowest target. $13.75’s average target is 97.84% above currents $6.95 stock price. Calithera Biosciences had 9 analyst reports since July 24, 2015 according to SRatingsIntel. The stock has “Sell” rating by Citigroup on Tuesday, October 25. The stock of Calithera Biosciences, Inc. (NASDAQ:CALA) earned “Buy” rating by Citigroup on Friday, July 24. H.C. Wainwright maintained it with “Buy” rating and $14 target in Tuesday, March 28 report. JMP Securities maintained Calithera Biosciences, Inc. (NASDAQ:CALA) on Wednesday, March 9 with “Market Outperform” rating. On Monday, June 12 the stock rating was maintained by H.C. Wainwright with “Buy”. As per Tuesday, January 24, the company rating was upgraded by Citigroup. The rating was initiated by H.C. Wainwright on Thursday, January 5 with “Buy”.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>